非布索坦价格多少呢？

A phase III clinical trial compared the efficacy of febuxostat (80 and 120 mg/d) with allopurinol (300 mg/d) in parallel. A 1-year study of 760 patients showed that compared with the allopurinol group, more patients in the febuxostat (febuxostat, feburic) group achieved the main trial efficacy indicator - the sUA concentration was measured below 60 mg/L in the last 3 months (all subjects were gout patients, and the pre-trial sUA concentrations were all above 80 mg/L); after 52 weeks of treatment, febuxostat (febuxostat, feburic) failed to significantly improve Reduce the area of tophi (tophi is an aggregate of urate crystals unique to gout), but this effect was more obvious in the high-dose group early in the trial; in each treatment group, patients with sUA concentrations reaching the target (<60mg/L) were less likely to have gout attacks, and their tophi area was more significantly reduced; adverse reactions and their incidence rates were similar in each treatment group, including abnormal liver function, diarrhea, headache, joint-related signs and symptoms, and musculoskeletal/connective tissue symptoms.

The therapeutic effect of febuxostat (febuxostat, feburic) is remarkable. So, how much does febuxostat cost?

The price of febuxostat (febuxostat, feburic) originally developed in Japan is relatively high, with the price of one box being around $1,000. Long-term use of the drug imposes a heavy financial burden on patients.

The generic version of febuxostat (febuxostat, feburic) produced by Zydus Pharmaceuticals in India has the same efficacy as the original drug, but the price is much cheaper. The specification is 80mg*30 tablets/box, and its price is about 100$. The specification is 40mg*100 tablets/box, and the price is about 200$. Prices will fluctuate due to exchange rate fluctuations. For specific price information, please consult the official overseas medical service company Medical Companion Travel.